The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a breast cancer (BC) polygenic risk score (PRS) on the decision to take preventive endocrine therapy (ET): The Genetic Risk Estimate (GENRE) trial.
 
Julian Oliver Kim
Research Funding - Varian Medical Systems (Inst)
 
Daniel J. Schaid
Travel, Accommodations, Expenses - Kaiser Permanente
 
Andrew Cooke
No Relationships to Disclose
 
Christina Kim
Research Funding - Celgene (Inst)
 
Benjamin Adam Goldenberg
No Relationships to Disclose
 
W Edward Highsmith
Stock and Other Ownership Interests - unknown
Patents, Royalties, Other Intellectual Property - unknown
 
Debjani Grenier
Honoraria - Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
Consulting or Advisory Role - Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
 
Jason P. Sinnwell
No Relationships to Disclose
 
Amy C. Degnim
Research Funding - TapImmune Inc. (Inst)
 
Fergus Couch
Consulting or Advisory Role - AstraZeneca
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL; Qiagen
Other Relationship - Ambry Genetics
 
Celine M Vachon
Research Funding - GRAIL
Patents, Royalties, Other Intellectual Property - Mayo Clinic
Travel, Accommodations, Expenses - GRAIL
 
Sandhya Pruthi
Patents, Royalties, Other Intellectual Property - Mytonomy- partnership (Inst)